Elena Arbelo
A5091302587- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Effects of Exercise
- Ion channel regulation and function
- ECG Monitoring and Analysis
- Cardiac Imaging and Diagnostics
- Cardiomyopathy and Myosin Studies
- Advanced MRI Techniques and Applications
- Cardiovascular Function and Risk Factors
- Cardiac Structural Anomalies and Repair
- Acute Myocardial Infarction Research
- Neurological disorders and treatments
- Health Systems, Economic Evaluations, Quality of Life
- RNA and protein synthesis mechanisms
- Viral Infections and Immunology Research
- Cardiac Arrest and Resuscitation
- Sports injuries and prevention
- Cardiac, Anesthesia and Surgical Outcomes
- Genomics and Rare Diseases
- Non-Invasive Vital Sign Monitoring
- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Cardiac Health and Mental Health
Universitat de Barcelona
2016-2025
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2016-2025
Centro de Investigación Biomédica en Red
2018-2025
Centro de Investigación en Red en Enfermedades Cardiovasculares
2018-2025
ERN GUARD-Heart
2022-2025
Hospital Clínic de Barcelona
2015-2024
Azienda Ospedaliera Universitaria Senese
2024
Barcelona Provincial Council
2024
Instituto de Salud Carlos III
2018-2022
Sant Joan de Déu Research Foundation
2022
Supplementary Table 9, column 'Edoxaban', row 'eGFR category', '95 mL/min' (page 15). The cell should be coloured green instead of yellow. It also read 60 mginstead mg (use with caution in 'supranormal' renal function).In the above-indicated cell, a footnote has been added to state: Edoxaban used patients high creatinine clearance only after careful evaluation individual thromboembolic and bleeding risk.Supplementary 'Dose reduction selected patients' 16). reduced 30 once daily if any...
Vedran Velagic (Croatia), Sami Viskin (Israel)
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
Poland), and Katja Zeppenfeld (
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge, evidence available at time their publication.The is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
ESC.
The ESC-EHRA Atrial Fibrillation Ablation Long-Term registry is a prospective, multinational study that aims at providing an accurate picture of contemporary real-world ablation for atrial fibrillation (AFib) and its outcome.A total 104 centres in 27 European countries participated were asked to enrol 20-50 consecutive patients scheduled first re-do AFib ablation. Pre-procedural, procedural 1-year follow-up data captured on web-based electronic case record form. Overall, 3630 included, which...
Ventricular tachycardia (VT) substrate ablation usually requires extensive ablation. Scar dechanneling technique may limit the extent of needed.The study included 101 consecutive patients with left ventricular scar-related VT (75 ischemic patients; ejection fraction, 36 ± 13%). Procedural end point was elimination all identified conducting channels (CCs) by at CC entrance followed abolition residual inducible VTs. By itself, scar rendered noninducibility in 54.5% increased to 78.2%. Patients...
The Atrial Fibrillation Ablation Pilot Study is a prospective registry designed to describe the clinical epidemiology of patients undergoing an atrial fibrillation (AFib) ablation, and diagnostic/therapeutic processes applied across Europe. aims 1-year follow-up were analyse how centres assess in routine practice success procedure evaluate rate long-term safety/complications.Seventy-two 10 European countries asked enrol 20 consecutive first AFib ablation procedure. A web-based case report...
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with European Association Cardio-Thoracic Surgery (EACTS)
Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains difficult and AF-related complications cause unacceptable morbidity mortality even on optimal current therapy. This document summarizes key outcomes 8th AFNET/EHRA Consensus Conference Atrial Fibrillation NETwork (AFNET) European Heart Rhythm Association (EHRA). Eighty-three international experts met Hamburg for 2 days October 2021. Results interdisciplinary, hybrid discussions breakout groups plenary...
Conduction system pacing (CSP) has emerged as an alternative to biventricular (BiVP). Randomized studies comparing both therapies are scarce and do not include left bundle branch pacing. This study aims compare ventricular resynchronization achieved by CSP vs BiVP in patients with cardiac therapy indication. LEVEL-AT (Left Ventricular Activation Time Shortening System Pacing Biventricular Resynchronization Therapy) was a randomized, parallel, controlled, noninferiority trial. Seventy...
Abstract Aims Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated risk AF-related complications. The aim this document to summarize key outcomes 9th AFNET/EHRA Consensus Conference Atrial Fibrillation NETwork (AFNET) European Heart Rhythm Association (EHRA). Methods results Eighty-three international experts met Münster for 2 days September 2023. Key findings...
Electrical storm (ES) is a state of electrical instability, manifesting as recurrent ventricular arrhythmias (VAs) over short period time (three or more episodes sustained VA within 24 h, separated by at least 5 min, requiring termination an intervention). The clinical presentation can vary, but ES usually cardiac emergency. mainly affects patients with structural primary heart disease, often implantable cardioverter-defibrillator (ICD). Management requires multi-faceted approach and the...
Background— Ventricular tachycardia (VT) ablation in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) has a low success rate. A more extensive epicardial (Epi) substrate could explain the efficacy. We report results of combined endocardial (Endo) and Epi VT conducting channel (CC) elimination. Methods Results— Eleven consecutive ARVD/C were included study. high-density 3D Endo (321±93 sites mapped) (302±158 electroanatomical voltage map was obtained during...